The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
8,499
Sort by:
Transferrin Receptor (TFR) - Drugs in Development, 2021
US$ 3,000.00
Transferrin Receptor (TFR) - Drugs in Development, 2021 SUMMARY Transferrin Receptor (TFR) - Drugs in Development, 2021 provides in depth analysis on Transferrin Receptor (TFR) targeted pipeline thera...
April 2021
35 pages
Trauma (Other Diseases) - Drugs in Development, 2021
US$ 2,000.00
Trauma (Other Diseases) - Drugs in Development, 2021 SUMMARY Trauma (Other Diseases) - Drugs in Development, 2021 provides an overview of the Trauma pipeline landscape. The report provides comprehensi...
April 2021
45 pages
Tubulin - Drugs in Development, 2021
US$ 3,500.00
Tubulin - Drugs in Development, 2021 SUMMARY Tubulin - Drugs in Development, 2021 provides in depth analysis on Tubulin targeted pipeline therapeutics. The report provides comprehensive information co...
April 2021
325 pages
Ulcers (Gastrointestinal) - Drugs in Development, 2021
US$ 2,000.00
Ulcers (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Ulcers (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Ulcers pipeline landscape. The report provides compreh...
April 2021
30 pages
Undisclosed (Undisclosed) - Drugs in Development, 2021
US$ 2,000.00
Undisclosed (Undisclosed) - Drugs in Development, 2021 SUMMARY Undisclosed (Undisclosed) - Drugs in Development, 2021 provides an overview of the Undisclosed pipeline landscape. The report provides co...
April 2021
40 pages
Urethral Cancer (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Urethral Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Urethral Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Urethral Cancer pipeline landscape. The report provi...
April 2021
60 pages
Uterine Cancer (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Uterine Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Uterine Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Uterine Cancer pipeline landscape. The report provides...
April 2021
110 pages
